Physician profile
David Rosen
NPI 1447332416
$5,140.76
in general payments reported to CMS, 2019-2025
11 companies · $1,517 in 2025
The $1,517 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.96 · 2020: $1,453 · 2021: $1,738 · 2022: $47.17 · 2023: $302 · 2024: $37.32 · 2025: $1,517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,517 · Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,517.00 |
| Food and Beverage | $338.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $3,112.50 | 2020-2021 | |
| Ge Healthcare | $1,517.00 | 2025 | |
| Lilly USA, LLC | $283.07 | 2022-2024 | Olumiant, Taltz, Zepbound |
| Sun Pharmaceutical Industries INC. | $52.89 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.17 | 2019-2023 | Xifaxan |
| Stryker Corporation | $37.69 | 2023 | N/A |
| Abbvie INC. | $23.78 | 2019 | |
| Leo Pharma INC. | $22.36 | 2021 | |
| Dermavant Sciences, INC. | $18.17 | 2023 | Vtama |
| Biofrontera INC. | $18.16 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.